SFCM
ABVX

Seven Fleet Capital Management’s Abivax ABVX Stock Holding History

Seven Fleet Capital Management’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.79M Buy
43,052
+29,553
+219% +$3.5M 1.51% 16
2025
Q4 		$1.82M Buy
+13,499
New +$1.47M 1.23% 13

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return

Seven Fleet Capital Management's ABVX Position: Q1 2026 in Review

Seven Fleet Capital Management increased its Abivax (ABVX) stake by 219% in Q1 2026, buying an estimated $3.5M and bringing the position to 43,052 shares worth $4.79M. The position accounts for 1.51% of the portfolio, ranked #16.

Seven Fleet Capital Management first reported a position in ABVX in Q4 2025 and has held it in 2 quarters since. 254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

  • Seven Fleet Capital Management held 43,052 shares of Abivax worth $4.79M as of Q1 2026.
  • Seven Fleet Capital Management bought 29,553 Abivax shares in Q1 2026, an estimated $3.5M.
  • Abivax made up 1.51% of Seven Fleet Capital Management's portfolio in Q1 2026, its #16 holding.
  • Seven Fleet Capital Management first reported a position in Abivax in Q4 2025 and has held it in 2 quarters since.
  • 254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on Seven Fleet Capital Management's 13F filing for Q1 2026, filed 15 May 2026.